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Abstract: There is growing evidence that omega-3 (n-3) polyunsaturated fatty-acids (PUFAs) are
important for the brain development in childhood and are necessary for an optimal health in adults.
However, there have been no studies examining how the n-3 PUFA composition of human milk
influences infant behavior or temperament. To fill this knowledge gap, 52 breastfeeding mothers
provided milk samples at 3 months postpartum and completed the Infant Behavior Questionnaire
(IBQ-R), a widely used parent-report measure of infant temperament. Milk was assessed for n-3
PUFAs and omega-6 (n-6) PUFAs using gas-liquid chromatography. The total fat and the ratio of n6/n-3 fatty acids in milk were also examined. Linear regression models revealed that infants whose
mothers’ milk was richer in n-3 PUFAs had lower scores on the negative affectivity domain of the
IBQ-R, a component of temperament associated with a risk for internalizing disorders later in life.
These associations remained statistically significant after considering covariates, including maternal
age, marital status, and infant birth weight. The n-6 PUFAs, n-6/n-3 ratio, and total fat of milk were
not associated with infant temperament. These results suggest that mothers may have the ability to
shape the behavior of their offspring by adjusting the n-3 PUFA composition of their milk.
Keywords: breastfeeding; breast milk; temperament; fatty acids; LC-PUFA; omega-3; omega-6;
DHA; AA; children; early life nutrition

1. Introduction
Early life nutrition plays a foundational role in brain development [1–3]. In recent decades,
research has shown that exposure to human milk and the variation in its composition contribute
meaningfully to children’s behavior, cognition, and disease risk [4–6]. The American Academy of
Pediatrics recommends that human milk be the sole source of infant nutrition for the first 6 months
of life [7], a sensitive period characterized by rapid brain development [2,3]. One key nutritional
factor that is present in human milk and that is necessary for an optimal brain development during
this period are omega-3 (n-3) polyunsaturated fatty-acids (PUFAs) [8,9].
Human milk contains relatively high levels of n-3 PUFAs, which are essential to visual, motor,
and cognitive development [8,9]. Among the 11 n-3 PUFAs, the three most important and prevalent
in human milk are alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic
acid (DHA) [5,10]. ALA is the most common n-3 PUFA in human milk [10] (and the adult diet) and
can be converted into EPA and DHA [11]. DHA is the most abundant n-3 PUFA in the central nervous
system in mammals and forms the structural matrix of grey matter and retinal membranes [9,12].
EPA is used to produce eicosanoids, signaling molecules that play numerous roles, including
reducing inflammation in the body and the brain [13,14]. The U.S. Department of Health and Human
Services 2015−2020 Dietary Guidelines for Americans recommend that all adults, particularly
pregnant and breastfeeding women, consume 8 ounces of seafood per week, providing
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approximately 250 mg of EPA and DHA per day [15]. Breast-fed infants have significantly higher
levels of n-3 PUFAs in their plasma lipids at three months than do infants given formula lacking n-3
fortification [16]. An autopsy study showed that the rate of accumulation of DHA is approximately
5.0 mg a day in the brains of breast-fed infants versus 2.3 mg a day in infants fed non-DHA fortified
formula [17].
Numerous studies have shown that deficiencies in n-3 PUFAs are related to mood and anxiety
disorders [18,19]. In adults, n-3 supplementation has benefits for the prevention and treatment of
major depression [20], bipolar disorder [21], and anxiety disorders [22]. Much less is known about
how early variations in the exposure to n-3 PUFAs impact the mood and behavior of children.
However, animal models suggest that early n-3 exposure can have a lasting impact on offspring
temperament and behavioral phenotypes. For example, feeding pregnant rats diets deficient in n-3
PUFAs increases anxiety-like behavior in rat pups, and upregulates anxiogenic-related glucocorticoid
receptors in the frontal cortex, hypothalamus, and hippocampus [23]. These pre-clinical studies are
consistent with correlational studies in human children. For example, in a diverse study of 255
women, eating a diet higher in n-3 relative to n-6 fatty acids during pregnancy buffered Black infants
against the detrimental effects of maternal stress on infant regulatory capacities [24]. Plasma DHA
levels have also been found to negatively correlate with depressive symptoms in children and
adolescents with bipolar disorder [25].
No studies, however, could be found examining whether the n-3 PUFA composition of milk
influences the infant mood or anxiety in humans, although several studies have linked cortisol levels
in milk to infant temperament [26–28]. For example, one study showed that higher levels of cortisol
in milk predicted an enhanced performance on the autonomic stability cluster on the Neonatal
Behavioral Assessment Scale in neonates [27]. Studies have also found that cortisol levels in mothers’
milk are positively correlated with a negative affectivity and fear reactivity in humans [26,28]. Most
of what we know about lactational programing comes from animal models, and findings are
generally consistent with the notion that milk is an important early moderator of the infant phenotype
[29–31]. For example, in a study of Rhesus Macaques, heavier mothers with more reproductive
experience were able to supply more calories to their infant through milk [32]. Moreover, infants
whose mothers supplied more calories through milk in the early postnatal period showed higher
activity levels and a greater confidence in a stressful setting later in infancy [32]. In sum, research has
neglected the question of whether the fatty acid composition of milk influences infant temperament
in humans.
To fill this gap, the current study tests whether the n-3 PUFA composition of mothers’ milk is
associated with the temperament of their infants. To address this question, milk samples were
collected from 52 mothers of 3-month old infants and assessed for n-3 PUFA levels using gas-liquid
chromatography. Mothers also completed the Rothbart Revised Infant Behavior Questionnaire (IBQR) [33], a widely-used parental-report instrument that assesses three broad dimensions of infant
temperament (negative affectivity, orienting/regulation, and surgency/extraversion). Given that n-3
PUFAs and higher n-3/n-6 ratios have been found to be protective against mood disorders and
anxiety symptoms [20], we predicted that n-3 PUFAs and the n-3/n-6 ratio in milk would be inversely
correlated with the negative affectivity dimension of the IBQ-R. n-3 PUFAs have also been linked to
enhanced executive functioning in children [9]. Therefore, we predicted that milk n-3 PUFAs levels
would be positively correlated with scores on the orienting/regulation temperament dimension. We
had no predictions regarding the surgency/extraversion temperament dimension. Exploratory
analyses are also presented; they test whether the levels of n-6 PUFAs, total PUFAs or total milk fat
concentrations are associated with infant temperament.
2. Methods
2.1. Participants
Fifty-two breastfeeding mothers and their three-month-old infants were enrolled in a large
longitudinal study of early development from a medical center in Southern California. To be eligible
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to participate in the study, participants had to be over the age of 18, English-speaking, with a
singleton intrauterine pregnancy. Women were ineligible for this study if they used alcohol, tobacco,
illicit drugs, had cervical or uterine abnormalities, used medications that impacted the endocrine
function, had a diagnosis of a disease influencing the neuroendocrine function, or had an infant
admittance to the Neonatal Intensive Care Unit at birth because of compromised health (e.g.,
intrauterine growth restriction and respiratory distress syndrome).
After mothers gave informed consent to participate in the study, they were asked to come into
the laboratory at 3 months postpartum (M = 3.01 months, SD = 0.25) to provide milk samples and fill
out a survey regarding their infants’ temperament. This study was approved by the Institutional
Review Board at the University of California, Irvine (ethics approval code HS# 2002−2441, first
approved: January 31, 2003; renewed most recently: February 25 2019).
2.2. Determination of Milk Fatty Acid Levels
Mothers were asked to empty the contents of one breast with an electric breast pump into a
sterile plastic container (Medela, Inc., McHenry, IL, USA). In an effort to ensure that the mother’s
milk donation for the study would not adversely impact infant nutrition, providing milk samples
was made an optional part of this larger longitudinal study, and mothers were only asked to empty
the contents of one breast, leaving milk in the other breast for the infant. Before the collection, the
mothers were asked to clean the breast and nipple area with an antibacterial wipe and wait until the
area dried (to leave open the possibility to examine the microbial composition of the milk for later
research). The milk samples were then immediately aliquoted into polypropylene tubes and stored
at 70 °C until they were assessed for fatty acids. The time of day of the milk collection was recorded
and modestly correlated with the n-3 fatty acid composition of the milk (Pearson’s r = −0.344, p =
0.015). The time of day of the sample collection was not related to any of the other fatty acids’
composite variables (Pearson’s r ranged from −0.175 to −0.008; ps > 0.153).
The fatty acid composition of the breast milk was analyzed by gas-liquid chromatography in
prepared fatty acid methyl esters. The total lipids were extracted from the milk by a method described
previously [34], using tridecanoin as the internal standard [35]. The thawed milk samples were
shaken vigorously and saponified in 6% ethanolic KOH for 1 h at 37 °C. The mixture was extracted
twice with hexane (20 min on rotator), and spun to separate the phases. The hexane layers were then
combined and evaporated under a gentle stream of nitrogen to reduce lipid peroxidation. The fatty
acid methyl esters were prepared by heating the reconstituted samples in 12% boron trifluoridemethanol for 10 min at 100 °C in tightly sealed tubes. The derivatized samples were separated with a
Hewlett-Packard gas chromatograph equipped with an Omegawax 250 capillary column and
isothermal oven.
The total of the n-3 PUFAs was computed by summing the total fats from ALA, EPA, DHA, and
a rare n-3 PUFA detected in milk, Eicosatrienoic acid (ETE). The total of the n-6 fatty acids was
computed by summing the total fats from Linolelaidic acid, Arachidic acid, Linoleic acid, Linolenic
acid, Dihomo-gamma-linolenic acid (DGLA), Arachidonic acid (AA), and Eicosadienoic Acid. The n6/n-3 PUFA ratio was computed by dividing the total fats from n-6 PUFAs by the total fats from n-3
PUFAs. Higher ratios represent milk that has more n-6 fatty acids relative to n-3s. The total PUFA
concentration in milk was determined by summing the levels of n-3 and n-6 PUFAs.
2.3. Infant Temperament
To assess the infant temperament, mothers were asked to fill out the Rothbart Revised Infant
Behavior Questionnaire (IBQ-R) during their laboratory visit [33]. The IBQ-R includes 191 specific
questions addressing concrete behaviors such as, “During a peek-a-boo game, how often did the baby
smile?” and “How often during the last week did the baby startle to a sudden or loud noise?” To
prevent errors in recall, the scale only asks mothers about recently occurring events, using a 7-point
Likert scale (1-never to 7-always). The IBQ-R measures three broad dimensions of temperament:
negative affectivity, surgency/extraversion, and orienting/regulation. The negative affectivity
dimension is created by averaging the scores across four subscales assessing infant sadness, fear,
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falling reactivity, and distress to limitations. The orienting/regulation dimension is created by
averaging across four subscales of mothers’ ratings of infants’ cuddliness/affiliation, low intensity
pleasure, duration of orienting, and soothability. The surgency/extraversion dimension is a
composite averaged from six subscales assessing infant approach, vocal reactivity, high intensity
pleasure, smiling and laughter, activity level, and perceptual sensitivity. This widely used parentalreport instrument has been shown to be reliable across parental reports [33] and to correlate well with
behavioral observations of infants [36]. The IBQ-R has been validated for use for infants aged 3 to 12
months, scores are relatively stable over the first year of life [36], and the scale takes approximately
30 min to complete [33]. As part of the larger longitudinal study, mothers also completed the IBQ-R
at 6 months. See Table S1 in the supplemental materials for exploratory analyses testing the
association between the milk fatty acid composition at 3 months and the infant temperament at 6
months.
2.4. Demographic and Health Information
Various demographic and health measures were tested as potential covariates. Maternal reports
of race/ethnicity, age, education level, income, parity, marital status, and breastfeeding exclusivity
were collected during a structured interview. A medical record review was conducted to assess the
birth outcomes, including the infant sex, gestational age at delivery, and birth weight and length. The
early pregnancy BMI (at 15 weeks) and weight gain during pregnancy (weight in pounds at 37 weeks15 weeks) were collected during laboratory visits as part of the larger longitudinal study. At 3
months, the infant weight was assessed using a digital scale (Midmark, Versailles, OH, USA), and
the height was determined while the child lay in a supine position. The child BMI percentiles (BMIP)
at birth and 3 months were calculated using an SPSS macro that fits the child’s height and weight to
standard WHO growth curves and generates a child’s BMI z-score standardized for age and sex
[37,38]. For ease of interpretation, these z-scores were converted to percentiles.
2.5. Statistical Analysis Strategy
First, preliminary analyses were performed to check that the variables were normally
distributed. Outliers that were greater than 3 standard deviations above or below the mean were
winsorized to bring them to within 2 standard deviations before the analysis. We planned to logtransform any skewed variables; however, after winsorization, all variables were normally
distributed. Second, we sought to identify potential confounds by testing whether demographic or
health characteristics were associated with fatty acid concentrations in milk. Linear regression models
were run with various demographic (age, income, education, marital status, race/ethnicity and infant
sex) and health (maternal BMI, weight gain in pregnancy, gestational age at birth, exclusive
breastfeeding status, and infant BMIP at birth and at 3 months) covariates entered simultaneously to
predict n-3, n-6, n-6/n-3 ratios, and the total milk fat. Demographic or health variables that were
associated with any one of the milk fatty acid composite variables with a p-value < 0.10 were included
as covariates in the subsequent analysis. For the primary analysis, a multivariate linear regression
was used to test whether the n-3, n-6, n-6/n-3 ratios, total PUFAs, or total milk fat predicted the
negative affectivity or orienting/regulation dimension of the IBQ-R, adjusting for potential
confounds. We also ran an exploratory analysis to see whether the fatty acid composition of milk was
associated with the surgency/extraversion factor. If there was a significant association, we then used
a follow-up linear regression analysis to test: (i) which specific sub-scales that made up the IBQ-R
temperament dimension were significantly related to the fatty acid composite, and (ii) which specific
fatty acid type (e.g., DHA vs. ALA) predicted the IBQ-R temperament dimension. Finally, we tested
whether infant sex or exclusive breastfeeding moderated any observed significant association
between the fatty acid levels and IBQ-R dimension. A moderation analysis was carried out by
creating cross products between the potential moderator (infant sex, exclusive breastfeeding) and
fatty acid levels, and the cross-products were then included in a linear regression model with the
constituent variables and covariates. All analyses were performed in SPSS version 21.0. The findings

Nutrients 2019, 11, 2964

5 of 12

were considered statistically significant if the p-values were under 0.05. The effect sizes (Standardized
Betas or β) are also provided for all analyses, regardless of the significance level.
3. Results
3.1. Preliminary and Descriptive Analyses
The demographic and health information of the samples is presented in Table 1. The fatty acids
composition of the milk samples are presented in Table 2. Several milk samples were more than three
standard deviations higher than the mean in terms of n-3 PUFA levels (n = 1), EPA levels (n = 2), ALA
levels (n = 1), and ETE levels (n = 1) and were winsorized to within 2 standard deviations of the mean
before the statistical analysis.
Table 1. Sample characteristics and their association with the fatty acid composition of the milk.
Mean/%
Maternal
Characteristics
Maternal age
Education
Household Income
Pre-Pregnancy BMI
Pregnancy Weight
Gain (lbs)
Parity (%
Primiparous)
Exclusive
Breastfeeding
% Married
Race/Ethnicity
% White

Standard
Deviation

Range

Omega-3

Omega-6

Stand. β

Stand. β

Omega-6/3
Ratio
Stand. β

Total Fat
Stand. β

29.67
2.70
69,489
24.17

4.86
1.051
33,980
5.98

19.2–39.9
0−4
25k–105k
16.4–47.4

0.407 t
0.113
0.008
−0.102

0.285
−0.014
−0.186
−0.086

−0.066
−0.167
−0.286
−0.045

0.254
−0.060
−0.181
−0.026

35.60

13.27

9.00–71.00

0.103

0.221

0.168

0.243

1−4

0.085

−0.053

−0.123

−0.076

63.27%

0.133

0.168

0.027

0.260

75%

−0.223

0.341

0.593 *

0.223

48.1%

58.3%

% Latina

18.8%

0.006

0.118

0.117

0.220

% Asian
% MultiEthnic/Other
Infant
Characteristics
Birth Weight
(grams)
Gestational Age at
Birth (weeks)
BMIP at Birth
BMIP at 3 mos
% Female Infants

10.4%

0.057

−0.006

−0.052

0.015

12.5%

−0.152

−0.011

0.170

−0.145

3465.49

386.874

2470–4220

0.104

0.405

0.449 t

0.215

39.6822

1.12

37.1–42.3

−0.093

−0.070

0.090

−0.147

56.92%
46.25%
48%

0.30
0.27

0.34–98%
0.02–97%

−0.114
0.164
0.117

−0.125
0.101
0.181

−0.175
−0.034
0.035

−0.164
−0.013
0.120

Note: Race/ethnicity was dummy coded to create contrasts to compare Hispanic, Asian, and MultiEthnic/Other groups to whites. Married was coded as 1 = Married, 0 = Not married; Infant sex was
coded as Female = 2, Male = 1. Bolded coefficients indicate those with p-values < 0.10 = t and p-values
< 0.05 = *. BMIP = Body Mass Index Percentile.
Table 2. Milk fatty acid concentrations.
IUPAC Name

(ug/mL)

Standard
Deviation
(ug/mL)

13.80

6.15

4.26–
42.25

0.74

1.02

0.02–7.00

Mean

Range
(ug/mL)

Omega-3 Fatty Acids
Linolenic acid (ALA)
Eicosatrienoic acid (ETE)

(9Z,12Z,15Z)-octadeca-9,12,15trienoic acid
(11Z,14Z,17Z)-icosa-11,14,17trienoic acid
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Eicosapentaenoic acid (EPA)
Docosahexaenoic acid (DHA)
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(5Z,8Z,11Z,14Z,17Z)-icosa5,8,11,14,17-pentaenoic acid
(4Z,7Z,10Z,13Z,16Z,19Z)docosa-4,7,10,13,16,19hexaenoic acid

1.09

1.16

0.06–7.00

2.72

1.91

0.77–
10.71

Omega-6 Fatty Acids
Linolelaidic acid

(9E,12E)-octadeca-9,12-dienoic
acid

1.16

0.30

1.00–3.08

Arachidic acid

(113C)icosanoic acid

194.60

72.78

65.12–
398.72

0.54

.06

0.51–0.89

2.26

1.71

0.14–8.79

5.41

2.21

1.41–
10.55

1.17

0.94

0.12–4.92

3.72

1.78

1.04–9.01

Total Omega-3

18.36

7.98

Total Omega-6

208.85

77.88

Omega-6/Omega-3 Ratio

12.12

4.36

Total Milk PUFAs

227.21

83.57

Total Milk Fat

942.51

346.76

Linoleic acid
Linolenic acid
Dihomo-gamma-linolenic acid
(DGLA)
Arachidonic acid (AA)
Eicosadienoic Acid

(9Z,12Z)-octadeca-9,12-dienoic
acid
(9Z,12Z,15Z)-octadeca-9,12,15trienoic acid
(8Z,11Z,14Z)-icosa-8,11,14trienoic acid
(5Z,8Z,11Z,14Z)-icosa5,8,11,14-tetraenoic acid
(11E,14E)-icosa-11,14-dienoic
acid

Composite Fatty Acid Variables
6.66–
55.64
70.11–
433.86
4.86–
27.14
83.58−489
.50
398–2301

See Table 1 for the results of the linear regression analysis testing for associations between
sociodemographic and health factors and the milk fatty acid composition. Married mothers had
significantly higher n-6/n-3 ratios in their milk than mothers who were not married (p = 0.010). Older
mothers tended to have higher levels of n-3 PUFAs in their milk (p = 0.060). Babies with a higher birth
weight also tended to have higher n-6/n-3 ratios in their milk (p = 0.086). Infant sex, gestational age at
delivery, and infant BMIP at birth or 3 months were not associated with the milk fatty acid
composition. Likewise, mothers’ pre-pregnancy BMI, weight gain in pregnancy, income, education,
exclusive breastfeeding status, parity and race/ethnicity did not predict fatty acid levels in milk.
Therefore, only the maternal age, marital status, and infant birth weight were included as covariates
in the subsequent linear regression models.
The average infant score on the surgency/extraversion factor was 3.92 (SD = 0.88), the negative
affectivity factor was 2.99 (SD = 0.56), and the orienting regulation factor was 5.02 (SD = 0.62). These
mean scores are similar to those reported in the original validation study that had a larger sample
size [33].
3.2. Primary Analysis
See Table 3 for the results of the multivariate linear regression analyses testing the association
between the fatty acid composite variables and the three primary temperament dimensions of the
IBQ-R. These analyses revealed that only higher levels of n-3 PUFA levels predicted lower scores on
the negative affectivity dimension (see Figure 1). This association remained statistically significant
after adjustment for the total milk fat content (β = −0.443, p = 0.023) and when all covariates were
removed from the model (β = −0.335, p = 0.015). In addition, controlling for the time of day of the milk
collection did not change the significant association between n-3 fatty acids and negative affectivity.
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Table 3. The association between the milk fatty acid composition and the infant temperament
assessed with multivariate linear regression models.

Negative Affectivity

Omega-3
Omega-6
Omega-6/3 ratio
Total PUFAs
Total Milk Fat

Standardized β
(p-value)
−0.352 (0.020) *
−0.249 (0.106)
0.134 (0.387)
−0.266 (0.083)
−0.124 (0.401)

Orienting
/Regulation
Standardized β
(p-value)
−0.014 (0.927)
0.131 (0.394)
0.159 (0.297)
0.127 (0.408)
−0.004 (0.981)

Surgency/Extraversion
Standardized β
(p-value)
−0.108 (0.479)
0.053 (0.727)
0.179 (0.236)
0.042 (0.784)
−0.039 (0.791)

Note: All coefficients are statistically adjusted for the maternal age, mother’s marital status, and infant
birth weight. * p < 0.05.

Figure 1. The scatterplot of the total omega-3 fatty acids in the milk and the infant negative affectivity.

Because the milk n-3 PUFA levels predicted a negative affectivity, we performed a follow-up
analysis to test how the n-3 PUFAs predicted each of the four subscales that comprised this dimension
of the IBQ-R. Higher n-3 PUFAs were associated with less sadness (β = −0.349, p = 0.021) and less
distress to limitations (β = −365, p = 0.017). Milk n-3s were not significantly related to infant fear (β =
−0.187, p = 0.219) or falling reactivity (β = −0.087, p = 0.584), although these effects were in the same
direction as those observed for sadness and limitations to distress.
In addition, given that n-3 PUFAs predicted negative affectivity, we tested whether specific
subtypes of n-3 PUFAs (ALA, EPA, DHA, or ETE) were, independently, related to negative
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affectivity. Mothers with higher ALA in their milk reported that their infants had significantly less
negative affectivity (β = −0.368, p = 0.015). Although they did not reach the criterion for statistical
significance, the DHA, EPA, and ETE levels were all negatively associated with negative affectivity
(DHA: β = −0.178, p = 0.229; EPA: β = −0.251, p = 0.095; ETE: β = −0.103, p = 0.472). Moderation Analysis
Neither the infant sex, nor the breastfeeding exclusivity, significantly moderated the association
between the milk n-3 PUFA levels and negative affectivity (sex: β = −0.170, p = 0.780; breastfeeding
exclusivity: β = 0.975, p = 0.071).
4. Discussion
The present study found evidence to support a link between the n-3 PUFA composition of
human milk and infant temperament. Specifically, infants whose mothers had higher levels of n-3
PUFAs in their milk were reported to display lower levels of negative affectivity at 3 months than
did infants whose mothers had lower levels of n-3 PUFAs in their milk. To the extent that negative
affectivity in infancy is associated with a higher risk for internalizing disorders in later childhood
[39,40], n-3 PUFAs in milk may represent a novel developmental origins pathway through which
environmental exposures influence the risk for later mental health disorders. To our knowledge, this
is the first study to report an association between the variation in the n-3 PUFAs levels in milk and
the temperament in humans. One previous study did report that there was no difference in the
temperaments of infants who were randomly assigned to receive formula supplemented with DHA
(vs. non-DHA-supplemented formula) [41] (see [42] for similar null results with rhesus macaques).
However, formula supplementation studies are not directly comparable to studies of human milk,
since n-3 PUFAs are metabolized differently in human milk than they are in formula [43], and since
the absorption of fatty acids from formula is highly dependent on the specific type of oil from which
the n-3s were harvested [44]. Still, the results of this study should be considered preliminary until
they can be replicated in larger studies.
There are several potential physiological pathways through which n-3 PUFAs in milk could
influence infant affect regulation and temperament. Most directly, n-3 PUFAs and their derivatives
help to regulate neurotransmission, and animal studies suggest that deficiencies increase the
serotonin 2 (5-HT2) and decrease dopamine 2 (D2) receptor density in the frontal cortex [45]. The
upregulation of 5-HT2 and downregulation of D2 in the brain have been implicated in mood disorders
[46]. Less directly, n-3 PUFAs might influence infant negative affectivity through inflammatory
pathways [18,19,47]. n-3 PUFAs, and EPA especially, have anti-inflammatory properties and reduce
the levels of pro-inflammatory cytokines [18,19,47]. In adults, we know from animal and human
experimental studies that pro-inflammatory cytokines can readily cross the blood–brain barrier and
induce sickness behavior characterized by depressive-like symptoms such as low mood, social
withdrawal, and anxiety [48]. The extent to which n-3s PUFAs regulate inflammatory processes in
early development is unknown, but future research could investigate if n-3 PUFAs’ levels in milk are
related to inflammatory processes in infants and if, by doing so, they indirectly influence negative
affectivity.
It was notable that, of the three primary types of n-3 PUFAs in milk, only higher levels of ALA
were significantly associated with negative affectivity. The DHA and EPA levels were also inversely
correlated with negative affectivity, but not to a statistically significant degree. It would be premature
for readers to conclude, however, that only ALA (and not DHA or EPA) in milk influences infant
temperament given that all three of the primary n-3 PUFAs were negatively correlated with negative
affectivity, with effect sizes in the small-to-medium range. Future studies that combine the methods
used here with direct assessments of infants’ plasma levels of ALA, DHA, and EPA are necessary to
address the question of whether it is n-3 PUFAs in general, or one subtype of n-3 PUFA in particular,
that influences infant temperament.
In their strongest form, these results could have several potential policy implications. First, the
maternal diet can influence the levels of n-3 PUFAs in milk and, by doing so, may influence infant
temperament. For example, breast milk EPA and DHA concentrations are closely linked to maternal
dietary EPA and DHA intake [49], and randomized control trials have shown that mothers given n-
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3 PUFA supplements show corresponding increases in the n-3 PUFA composition of their milk
[50,51]. Unfortunately, this study did not include information on maternal diets, and only two
mothers in our study reported taking omega-3 PUFA supplements, so we were not able to test this
hypothesis. Future studies could examine whether increasing the dietary intake of n-3 PUFAs in
breastfeeding women would lead to a reduced negative affectivity in infants. Second, considering
that negative affectivity in infancy predicts internalizing disorders (i.e., anxiety/depression) in later
childhood [39,40], perhaps supplementing breastfeeding mothers with n-3 PUFAs could help
ameliorate the risk for later mental health problems. While this possibility is only hypothetical,
maternal diets during pregnancy and lactation are modifiable and present promising targets for the
prevention of adverse developmental outcomes in children [52,53].
Although this study had several strengths, including the direct assessment of the fatty acid
composition of milk and the carefully characterized cohort, these results should be considered in the
context of several limitations. First, we relied on maternal reports of infant temperament, which may
be biased. Despite this, the IBQ-R has in previous studies been found to correlate highly with more
objective measures of infant temperament (e.g., behavioral observations) [36]. Moreover, the
association between the reports of mothers and other caregivers is generally high [33]. Still, future
research would benefit from including additional object measures of infant temperament and
behavior. Second, this study was correlational and cannot rule out the possibility that a confounding
factor may explain the observed association between the n-3 PUFA levels in milk and infant
temperament. To address this possibility, we tested whether a number of demographic (e.g., income,
education) and health (e.g., maternal BMI, weight gain in pregnancy) factors predicted the fatty acid
composition of milk. Only the marital status, maternal age, and infant birth weight predicted the fatty
acid composition of milk, and statistically adjusting for these covariates did not negate the association
between n-3 PUFA levels and negative affectivity in this study. Regardless, there are numerous bioactive factors in milk, such as cortisol, which have been shown to correlate with total milk fat [54]
and negative affectivity in infants [26]. However, given that we found no association between the
total fat or n-6 fatty acid content of milk and infant temperament, we believe that the n-3 composition
of milk and cortisol levels in milk likely represent distinct lactational programming pathways.
Furthermore, the association between n-3 PUFA levels in milk and negative affectivity remains
statistically significant after adjusting for the total fat content of the milk, suggesting that it is n-3
PUFAs specifically, and not richer milk generally, that shapes infant temperament. Finally, this study
did not include information on the last time mothers had breastfed or on the total milk volume that
mothers expressed. We were unable to identify any studies that tested how the time since the last
feeding or the volume of milk production impacts the omega-3 fatty acid composition of milk. Future
research is needed to determine whether these factors are associated with LC PUFAs and could
therefore have influenced these results.
Findings from this study add to the growing body of research demonstrating that the variation
in the composition of mothers’ milk plays an important role in shaping the development of offspring.
Specifically, we found that milk that was richer in n-3 PUFAs was associated with reduced sadness
and distress in infants. These new data are consistent with previous research linking n-3 PUFAs to
an improved mood and mental health in adults [18–22]. We hope that the exciting research taking
place in the field of lactational programming will open up new possibilities for preventing mood
disturbances.
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Table S1: Exploratory
analysis of the association between the fatty-acid concentration of milk at 3-months and negative affectivity at
6-months (n = 44).
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